NDC 0006-0571

CRIXIVAN

Indinavir Sulfate

CRIXIVAN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Indinavir Sulfate.

• Product ID: 0006-0571_2f1ee2da-8e76-4c4e-8006-285449f74f1b
• NDC: 0006-0571
• Product Type: Human Prescription Drug
• Proprietary Name: CRIXIVAN
• Generic Name: Indinavir Sulfate
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 1996-03-13
• Marketing Category: NDA / NDA
• Application Number: NDA020685
• Labeler Name: Merck Sharp & Dohme Corp.
• Substance Name: INDINAVIR SULFATE
• Active Ingredient Strength: 200 mg/1
• Pharm Classes: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0006-0571-43

360 CAPSULE in 1 BOTTLE (0006-0571-43)

• Marketing Start Date: 1996-03-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-0571-43 [00006057143]

CRIXIVAN CAPSULE

• Marketing Category: NDA
• Application Number: NDA020685
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1996-03-13

Drug Details

Active Ingredients

Ingredient	Strength
INDINAVIR SULFATE	200 mg/1

OpenFDA Data

• SPL SET ID: e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • 771H53976Q
• RxNorm Concept Unique ID - RxCUI:
  • 541058
  • 310986
  • 310988
  • 153128
  • 283103
  • 153127
• UPC Code:
  • 0300060570629

Pharmacological Class

• HIV Protease Inhibitors [MoA]
• Protease Inhibitor [EPC]
• Cytochrome P450 3A4 Inhibitors [MoA]

NDC Crossover Matching brand name "CRIXIVAN" or generic name "Indinavir Sulfate"

NDC	Brand Name	Generic Name
0006-0571	CRIXIVAN	indinavir sulfate
0006-0573	CRIXIVAN	indinavir sulfate
21695-366	CRIXIVAN	indinavir sulfate
53808-0661	CRIXIVAN	indinavir sulfate